INGENIOUS TARGETING LABORATORY INC.

Ingenious Targeting Laboratory Inc. specializes in advanced genetic model development and laboratory testing services, with a focus on precision biomedical research tools. The company delivers customized conditional knock-in mouse models using CRISPR and transgenic technologies, enabling targeted gene expression studies for biomedical discovery. Their technical expertise includes molecular cloning, DNA cassette design, embryonic stem cell manipulation, and phenotypic validation of genetically engineered animal models. They also provide specialized laboratory support for administrative and regulatory closeout of federally funded research projects, demonstrating proficiency in compliance-driven scientific operations and grant lifecycle management. The contractor maintains a focused relationship with the Department of Health and Human Services, particularly through agencies such as the National Institutes of Health’s National Institute of Child Health and Human Development. Their work supports preclinical research initiatives requiring genetically accurate animal models and rigorous laboratory protocol adherence, indicating a strong alignment with NIH-funded translational science programs. Their primary industry focus lies in testing laboratories and support activities for animal production, positioning them as a niche provider in preclinical research infrastructure. They serve the biomedical research sector by delivering bespoke genetic models and specialized lab services critical to drug development, gene therapy, and disease mechanism studies. Their market positioning is defined by technical precision in genetic engineering rather than broad-scale contract manufacturing. Ingenious Targeting Laboratory Inc. is a small business structured as a 2L entity, headquartered in Ronkonkoma, New York. While currently holding no formal government certifications, their demonstrated capability in genetically modified organism development and federal research support underscores a specialized, mission-driven presence in the life sciences contracting space. Their geographic footprint is centered in the Northeast, with operations tailored to serve federal research institutions requiring high-complexity, low-volume genetic model development.